The role of myelin damage in Alzheimer's disease pathology

Ewa Papuć1, Konrad Rejdak1,2

  • 1Department of Neurology, Medical University of Lublin, Lublin, Poland.

Insights

Myelin damage, overlooked for decades in Alzheimer's disease (AD), is now recognized as crucial. This review explores myelin's role and interaction with amyloid-beta and tau pathologies in AD.

Area of Science:

  • Neuroscience
  • Neuropathology
  • Demyelinating Diseases

Background:

  • Alzheimer's disease (AD) has historically been viewed as a grey matter disorder.
  • Alois Alzheimer's early 1911 observation of myelin disruption in AD was largely ignored.
  • Emerging evidence highlights the significant role of myelin impairment in AD pathology.

Purpose of the Study:

  • To provide an overview of the current understanding of myelin's role in Alzheimer's disease.
  • To examine the interactions between myelin pathology and hallmark AD pathologies (Aβ and tau).
  • To discuss whether myelin damage is a primary or secondary event in AD.

Main Methods:

  • Review of existing literature on myelin pathology in Alzheimer's disease.
  • Analysis of the relationship between myelin damage and Aβ/tau accumulation.
  • Synthesis of evidence regarding the temporal sequence of pathological events in AD.

Main Results:

  • Oligodendrocyte death and myelin damage can be induced by classical AD neuropathological changes (Aβ plaques, neurofibrillary tangles).
  • Myelin pathology may precede the development of Aβ and tau pathologies in some cases of AD.
  • The precise causal relationship (primary vs. secondary injury) of myelin damage in AD remains undetermined.

Conclusions:

  • Myelin disruption is an important, though historically underappreciated, feature of Alzheimer's disease pathology.
  • Understanding myelin's role is critical for a comprehensive view of AD pathogenesis.
  • Further research is needed to elucidate the exact timing and contribution of myelin damage in AD progression.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
697
Nervous Tissue: Myelin01:25

Nervous Tissue: Myelin

The myelin sheath is a multilayered lipid and protein covering that insulates the axon of a neuron, enhancing the speed of nerve impulse conduction. Axons without this sheath are referred to as unmyelinated. Two types of neuroglia, Schwann cells in the peripheral nervous system (PNS) and oligodendrocytes in the central nervous system (CNS) are responsible for producing myelin sheaths.
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
5.0K
Role of Neurotransmitters in Memory01:23

Role of Neurotransmitters in Memory

Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
 Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
2.3K
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
11.5K